Atropos Health

Generating an observational study from a natural language question is the product. The model translates a clinical question into a study design, executes it against the federated data network, and returns publication grade evidence, which is inference doing analytical work rather than retrieval.

The design directly targets the failure mode that matters in clinical evidence. The company states plainly that hallucinations are unacceptable in this field and built the framework to eliminate that risk by grounding every answer in an executed study against real patient data rather than generating prose from a model's parameters. Combined with the per answer fitness score and publication grade study output that a clinician or researcher can inspect, the human retains the ability to evaluate the evidence rather than trust the assistant.

Two disclosures put this among the strongest on this axis. First, ChatRWD is stated as an LLM independent framework, so an institution can maintain its own model security and integrity rather than inheriting the vendor's model choice, which is a genuine architectural commitment and rare. Second, every answer carries a Real World Fitness Score rating how fit for purpose the underlying dataset was for that specific question, with a reported average of 79.8 across a 2,000 question beta evaluation. Publishing a per answer quality score is an explicit admission that evidence quality varies by question, and it hands the user the means to discount a weak result.

Provenance is academic rather than commercial: the company spun out of Stanford's Green Button project, and Stanford Health Care has since moved from using the service to embedding it in physician workflow and clinical notes, with a pilot evaluating provider satisfaction and use of the evidence in treatment decisions. Adoption reported through First Edition partners reaches roughly a third of US physicians and about half of major US health systems. The company reports ChatRWD answers clinical questions more accurately than general models including ChatGPT and Gemini, which is vendor stated and should be verified independently.

No public pricing. Contact the vendor. Two commercial surfaces: health system and academic medical center agreements for clinical use, and separately negotiated life sciences engagements. The Atropos Evidence Agent is additionally distributed through the Databricks Marketplace, which may offer a different procurement path for organizations already on that platform.

Scope is defined by the question rather than the specialty, which is the right framing for evidence generation: any clinical question answerable from the federated network, spanning bedside decisions, life sciences research, and guideline development. The federated network is reported to exceed 300 million anonymized patient records.